Citations 0
Capitol Health Call
August 12, 2009

Funding Transparency

JAMA. 2009;302(6):619. doi:10.1001/jama.2009.1122

Senators who previously called for increased transparency in the financial relationships between physicians and manufacturers of drugs, devices, and biologics are now pressing for such openness among researchers who receive grants from the National Institutes of Health (NIH).

In a July 7 letter, Sen Chuck Grassley (R, Iowa) and Sen Herb Kohl (D, Wis) said the NIH should require its grantees to report outside income to the nearest $1000 and oblige universities to complete plans to manage potential conflicts of interest ( In addition, information on both actions should be posted on the NIH's Web site, the letter said.

First Page Preview View Large
First page PDF preview
First page PDF preview